HLX26 is a humanized anti-LAG-3 monoclonal antibody with antitumor properties, making it particularly useful for advanced solid tumors. Additionally, HLX26 can be applied in lymphoma research.
Target:
LAG-3
* VAT and and shipping costs not included. Errors and price changes excepted
